Skip to content
value.today

Nerveda Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2007
Total raised
$18 M
2 rounds on record
Latest round
$4 M
Jul 2011
First round on record
Jun 2007
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Nerveda Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2011$4 MNo. 2$2 to $10 million

Nerveda Inc.: Raise no. 2, Jul 2011

Investors in this round

36 investors had bought by the notice of Aug 3, 2011: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $8 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Cam Gallagher · Executive Officer, Director, Promoter
  • David Maurer-Hollaender · Director
  • Debra Widmann · Director
  • James Weil · Director
  • Rob Ades · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cam Gallagher, President. Source: SEC Form D, newest notice filed Aug 3, 2011. Read the notice at the SEC.

equitySEC
Jun 2007$14 MNo. 1$10 to $50 million

Nerveda Inc.: Raise no. 1, Jun 2007

Investors in this round

55 investors had bought by the notice of Apr 12, 2010: 55 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $27 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cam Gallagher · Executive Officer, Director, Promoter
  • Adam Cohen · Director
  • Debra Widmann · Director
  • Odo Habeck · Director
  • Rob Ades · Director
  • Stewart Reid · Director
  • Thomas Lionelli · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cam Gallagher, President & CEO. Source: SEC Form D, newest notice filed Apr 12, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Nerveda Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2011).

    SEC Form D · Aug 2011

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2011

That is all the official record says: Nerveda Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Nerveda Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 55 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Nerveda Inc.
NameRoleNamed in
Cam GallagherExecutive officerAug 2011
Cam GallagherDirectorAug 2011
David Maurer-HollaenderDirectorAug 2011
Debra WidmannDirectorAug 2011
James WeilDirectorAug 2011
Rob AdesDirectorAug 2011
Adam CohenDirectorApr 2010
Odo HabeckDirectorApr 2010
Stewart ReidDirectorApr 2010
Thomas LionelliDirectorApr 2010
Cam GallagherPromoterAug 2011